h-header

news

News dal mondo

22

Set

EU Politicians: 'Bring Pharma Manufacturing Back To Europe'

The European Parliament says the coronavirus pandemic has exposed the hazards of the EU’s reliance on third countries for medicines supply and has proposed that its vulnerability to drug shortages should be addressed by offering pharmaceutical companies incentives to bring some manufacturing back to Europe.



“Priority needs to be given to boosting domestic production of essential and strategic medicines as currently 40% of medicines marketed in the EU originate in non-EU countries, while 60-80% of active pharmaceutical ingredients are produced in China and India,” according to members of the parliament (MEPs).



MEPs also want to see more flexible rules on packaging to allow medicine packs to circulate more freely among EU member states, and have called for the establishment of a European contingency reserve of “medicines of strategic importance” and an expansion in the use of joint procurement of drugs at EU level.....[Resolution EU 18 Septemebr 2020]

23

Ott

AIFA - Comunicazione su medicinali contenenti rifampicina

Le  Autorità dell’Unione Europea stanno indagando in merito  alla presenza...

22

Ott

Aggiornamento delle monografie USP dell'alcol etanolo e anidro etanolo assoluto

lla fine di agosto 2020 FDA ha chiesto a USP di includere un test nella sezione di identificazione...

21

Ott

A Quality Agreement Primer: Reviewing Regulations & Enforcement Activity

With many companies utilizing contract manufacturing and contract laboratories, quality agreements...

slider-banner

h-footer
pager